Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss
NCT04370093Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2019
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in nephrolithiasis, sponsored by UT Southwestern Medical Center. Started Oct 2019; status: completed.
02
Drugs
pioglitazone
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT04370093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370093.